H&M USA Funding: How Much Did They Raise & Key Investors

How Much Did H&M USA Raise?
Funding & Key Investors

H&M USA, a key player in the distribution of health and wellness ingredients, has secured $150K in total capital, with a recent strategic investment of $150K. This significant backing underscores the company's established position in supplying Vitamins, Amino Acids, Botanical & Herbal Extracts, and Pharmaceuticals to a diverse clientele.

What is H&M USA?

H&M USA

Retail

Drug Stores & Pharmacies

Vitamins, Supplements & Health Stores

H&M USA operates as a premier distributor within the health and wellness, food, and pharmaceutical sectors. The company specializes in providing high-quality ingredients such as Vitamins, Amino Acids, Botanical & Herbal Extracts, Specialty Materials, Food Ingredients, Sweeteners, and Pharmaceuticals. Their commitment to quality and customer satisfaction has solidified their reputation as a trusted source for essential materials, catering to a broad spectrum of industry needs.

How much funding has H&M USA raised?

H&M USA has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

What's next for H&M USA?

The recent major strategic investment signifies a pivotal moment for H&M USA, indicating a strong investor confidence in its market trajectory and operational capabilities. This capital infusion is expected to fuel further expansion, potentially enhancing supply chain efficiencies, broadening product portfolios, and deepening market penetration within the health, wellness, and pharmaceutical industries. The company is poised for continued growth and innovation in ingredient distribution.

See full H&M USA company page

See More Financial Insights